tailieunhanh - Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: The ABLATIVE-2 trial—a study protocol

Partial breast irradiation (PBI) is standard of care in low-risk breast cancer patients after breast-conserving surgery (BCS). Pre-operative PBI can result in tumor downstaging and more precise target definition possibly resulting in less treatment-related toxicity. This study aims to assess the pathologic complete response (pCR) rate one year after MR-guided single-dose pre-operative PBI in low-risk breast cancer patients. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN